| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―May―25 |
The Association of Vaping With Social/Emotional Health and Attitudes Toward COVID-19 Mitigation Measures in Adolescent and Young Adult Cohorts During the COVID-19 Pandemic |
Alicia L. Oliver, Joe Kossowsky, Machiko Minegishi, Sharon Levy, Elissa R. Weitzman |
| 2 |
[GO] |
2022―Jul―27 |
Trends in buprenorphine treatment disparities during the COVID pandemic in Massachusetts |
Sarah E. Wakeman, Eugene Lambert, Sunny Kung, Nicholas M. Brisbon, Aleta D. Carroll, Thu-Trang Hickman, et al. (+3) Charles Covahey, Thomas D. Sequist, Scott G. Weiner |
| 3 |
[GO] |
2022―May―02 |
A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19 |
Rachel Lockard, Kelsey C. Priest, Jessica Gregg, Bradley M. Buchheit |
| 4 |
[GO] |
2022―May―02 |
Cannabis dispensary online marketing practices in response to COVID-19 lockdowns |
Pamela M. Ling, Eric Crosbie, Louisa M. Holmes, Christine Hoang, Samantha Hoeper |
| 5 |
[GO] |
2022―Apr―26 |
Alcohol consumption and alcohol home delivery laws during the COVID-19 pandemic |
Elyse R. Grossman, Sara E. Benjamin-Neelon, Susan Sonnenschein |
| 6 |
[GO] |
2022―Apr―18 |
Perceived impact of COVID-19 on prevention, treatment, harm reduction, and recovery services for opioid use disorder: National survey of local health departments |
William L. Swann, Terri L. Schreiber, Serena Y. Kim, Heidi McNeely, Jake H. Hong |
| 7 |
[GO] |
2022―Apr―18 |
A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic |
Terence M. Hughes, Alexander Kalicki, Zina Huxley-Reicher, Wilma Toribio, Don L. Samuels, Jeffrey J. Weiss, et al. (+2) Michael Herscher, Linda Wang |
| 8 |
[GO] |
2022―Feb―18 |
How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data |
Oliver Grundmann, Charles A. Veltri, Diana Morcos, David Knightes III, Kirsten E. Smith, Jeffery M. Rogers |
| 9 |
[GO] |
2022―Feb―18 |
Preparing for the future of medical education: A case series of traditional and virtual clinical rotations in addiction medicine spanning the COVID pandemic |
Curtis Bone, Nils Wendel, Shou Ling Leong, Bethany Snyder, Heather Costigan, Joy Bowen, et al. (+7) Jarrett Sell, Sarah Kawasaki, David Giampetro, Don Dissinger, Bill Milchak, Alexis Reedy-Cooper, Heather Stuckey |
| 10 |
[GO] |
2022―Feb―03 |
Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients |
Jared Wildberger, Kevin Wenzel, Marc Fishman |
| 11 |
[GO] |
2022―Jan―31 |
Clinical and demographic differences in the willingness to use self-administered at-home COVID-19 testing measures among persons with opioid use disorder |
Colleen B. Mistler, Matthew Sullivan, Jeffrey A. Wickersham, Michael M. Copenhaver, Roman Shrestha |
| 12 |
[GO] |
2021―Oct―20 |
COVID-19-Related Policy Changes for Methadone Take-Home Dosing: A Multistate Survey of Opioid Treatment Program Leadership |
Ximena A. Levander, Jarratt D. Pytell, Kenneth B. Stoller, P. Todd Korthuis, Geetanjali Chander |
| 13 |
[GO] |
2021―Sep―14 |
Collaboration in a time of crisis: Adapting a telementoring ECHO for addiction leaders during COVID-19 |
Honora Englander, Alisa Patten, Jessica Gregg |
| 14 |
[GO] |
2021―Sep―14 |
Opioid treatment programs, telemedicine and COVID-19: A scoping review |
Brian Chan, Christina Bougatsos, Kelsey C. Priest, Dennis McCarty, Sara Grusing, Roger Chou |
| 15 |
[GO] |
2021―Jul―20 |
Addiction medicine in the time of COVID-19: An overview of the 2020 Joint Scientific Annual Conference of the International Society of Addiction Medicine and Canadian Society of Addiction Medicine |
Marc N. Potenza, Nady el-Guebaly |
| 16 |
[GO] |
2021―Jul―08 |
Contextual challenges in police-assisted substance use referral programs: Impact of COVID-19 and Black Lives Matter movement |
Jessica Liu, Emily Heckel, Adina Coroiu, Vaughan W. Rees |
| 17 |
[GO] |
2021―Jul―07 |
Are COVID-19 health-related and socioeconomic stressors associated with increases in cannabis use in individuals who use cannabis for recreational purposes? |
Sharon Sznitman, Dennis Rosenberg, Nehama Lewis |
| 18 |
[GO] |
2021―Jun―05 |
Changes in young adult substance use during COVID-19 as a function of ACEs, depression, prior substance use and resilience |
Katelyn F. Romm, Brooke Patterson, Natalie D. Crawford, Heather Posner, Carly D. West, DeEnna Wedding, et al. (+2) Kimberly Horn, Carla J. Berg |
| 19 |
[GO] |
2021―May―19 |
Associations of alcohol, marijuana, and polysubstance use with non-adherence to COVID-19 public health guidelines in a US sample |
Michael Fendrich, Jessica Becker, Crystal Park, Beth Russell, Lucy Finkelstein-Fox, Morica Hutchison |
| 20 |
[GO] |
2021―Apr―15 |
Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis |
Jessica Ristau, Nicky Mehtani, Seth Gomez, Michelle Nance, Devora Keller, Colleen Surlyn, et al. (+2) Joanna Eveland, Shannon Smith-Bernardin |
| 21 |
[GO] |
2021―Apr―15 |
A health crisis within a health crisis: Opioid access in the COVID-19 pandemic |
Aditya Narayan, Rajesh Balkrishnan |
| 22 |
[GO] |
2021―Mar―12 |
Alcohol sales during COVID-19 social restrictions: Initial evidence from Alcoholic Beverage Control states |
Cory M. Morton |
| 23 |
[GO] |
2021―Mar―08 |
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management |
Nicky J. Mehtani, Jessica T. Ristau, Hannah Snyder, Colleen Surlyn, Joanna Eveland, Shannon Smith-Bernardin, Kelly R. Knight |
| 24 |
[GO] |
2020―Oct―12 |
Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic |
S. J. Bartel, S. B. Sherry, S. H. Stewart |
| 25 |
[GO] |
2020―Sep―24 |
Identifying #addiction concerns on twitter during the COVID-19 pandemic: A text mining analysis |
Elizabeth M. Glowacki, Gary B. Wilcox, Joseph B. Glowacki |
| 26 |
[GO] |
2020―Sep―16 |
Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder |
Allison M. Gustavson, Adam J. Gordon, Marie E. Kenny, Haley McHenry, Julie Gronek, Princess E. Ackland, Hildi J. Hagedorn |
| 27 |
[GO] |
2020―Jul―22 |
On the efficacy of online drug surveys during the time of COVID-19 |
Joseph J. Palamar, Patricia Acosta |
| 28 |
[GO] |
2020―Jul―22 |
COVID-19 and persons with substance use disorders: Inequities and mitigation strategies |
Osnat C. Melamed, Tanya S. Hauck, Leslie Buckley, Peter Selby, Benoit H. Mulsant |
| 29 |
[GO] |
2020―Jul―22 |
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic |
Gerald Cochran, Julie Bruneau, Nicholas Cox, Adam J. Gordon |
| 30 |
[GO] |
2020―Apr―21 |
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment |
Traci C. Green, Jeffrey Bratberg, Deborah S. Finnell |
